Compliance with allergen immunotherapy

Area of Science:

• Allergy and Immunology
• Pediatric Medicine
• Health Services Research

Background:

• Immunotherapy has been a treatment for allergic rhinitis since 2000.
• Assessing patient compliance with immunotherapy is crucial for treatment efficacy.
• Allergic rhinitis affects children and adolescents, necessitating adherence to treatment plans.

Purpose of the Study:

• To evaluate the compliance rates of immunotherapy in pediatric patients with allergic rhinitis.
• To identify factors associated with immunotherapy compliance in this patient group.

Main Methods:

• A retrospective chart review of 315 patients (aged 5-18) prescribed immunotherapy for allergic rhinitis for at least one year.
• Log-linear analysis was used to examine relationships between payment source, demographics, allergen sensitization, and compliance.
• Data on co-existing conditions like asthma and atopic dermatitis were also analyzed.

Main Results:

• Private patients (59%) showed higher compliance than nonprivate patients (46%).
• Compliance rates were 61% for asthmatic patients and 47% for those with atopic dermatitis.
• Male and Caucasian patients demonstrated slightly higher compliance rates. Compliance was not influenced by the number of allergen sensitivities.

Conclusions:

• Source of payment significantly impacts immunotherapy compliance in pediatric allergic rhinitis patients.
• Understanding demographic and clinical factors can help improve adherence strategies.
• Further research into barriers for nonprivate patients is warranted to optimize treatment outcomes.